Maxwell Biomedical - About the company
Maxwell Biomedical is a seed company based in Solana Beach (United States), founded in 2019. It operates as a Developer of smart devices for atrial fibrillation. Maxwell Biomedical has raised an undisclosed amount in funding. The company has 66 active competitors, including 17 funded and 15 that have exited. Its top competitors include companies like Lifetech Scientific Corporation, Silk Road Medical and Supira Medical.
Company Details
Maxwell Biomedical is a developer of smart devices for atrial fibrillation. It has developed a smart device that helps to diagnose many diseases such as stroke, heart failure, hypertension, coronary artery disease, valvular heart disease, cardiomyopathy, diabetes, obesity, sleep apnea, and others. The device helps to reduce the risk of stroke, and procedures such as cardioversion, catheter ablations to restore normal heart rhythm. It helps to kill tissue inside the heart to destroy the tissue causing the abnormality in the heart's electrical circuits.
- Website
- www.maxwellbiomedical.com/
- Phone Number
- +1 **********
Key Metrics
Founded Year
2019
Location
Solana Beach, United States
Stage
Seed
Latest Funding Round
Investors
Ranked
31st among 66 active competitors
Employee Count
13 as on Mar 31, 2026
Investment & Acquisitions
Similar Companies
Sign up to download Maxwell Biomedical's company profile
Maxwell Biomedical's funding and investors
Maxwell Biomedical has raised funding over 2 rounds. Its first funding round was on Jul 22, 2020. Its latest funding round was a Grant (prize money) round on Sep 15, 2022 for $*****. 1 investor participated in its latest round. Maxwell Biomedical has 3 institutional investors.
Here is the list of recent funding rounds of Maxwell Biomedical:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Sep 15, 2022 | 9797668 | Grant (prize money) | 3633491 | 5703334 | 5322525 | 8743759 |
Jul 22, 2020 | 8476527 | Seed | 5794828 | 8455876 | 6183243 | 2967943 |
View details of Maxwell Biomedical's funding rounds and investors
Maxwell Biomedical's founders and board of directors
Founder? Claim ProfileMaxwell Biomedical's employee count trend
Maxwell Biomedical has 13 employees as of Mar 26. Here is Maxwell Biomedical's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Maxwell Biomedical's Competitors and alternates
Top competitors of Maxwell Biomedical include Lifetech Scientific Corporation, Silk Road Medical and Supira Medical. Here is the list of Top 10 competitors of Maxwell Biomedical, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Lifetech Scientific Corporation 1999, Shenzhen (China), Public | Interventional medical devices to treat cardiovascular and peripheral vascular diseases. | $66.2M | 63/100 | |
2nd | Silk Road Medical 2007, Sunnyvale (United States), Acquired | Provider of neuroprotection devices for carotid artery disease | $189M | 63/100 | |
3rd | Supira Medical 2016, Campbell (United States), Series E | Developer of ventricular assist devices for coronary intervention and cardiogenic shock | $240M | 59/100 | |
4th | AMT Medical 2016, Utrecht (Netherlands), Series B | Providing solutions for heart bypass surgery | $36.7M | 55/100 | |
5th | AVS Pulse 2017, Ann Arbor (United States), Series B | Developer of a medical device to treat severely calcified arterial disease | $70.4M | 55/100 | |
6th | Coronary stenting system | - | 48/100 | ||
7th | SIS Medical 2006, Winterthur (Switzerland), Late Stage | Distributor of medical and surgical supplies | - | 47/100 | |
8th | CardiacBooster 2018, Nijmegen (Netherlands), Funding Raised | Provider of percutaneous left ventricular assist devices | - | 45/100 | |
9th | Protaryx Medical 2019, Baltimore (United States), Series A | Developer of smart medical devices for the treatment of atrial septum of the heart diseases | $8.3M | 41/100 | |
10th | Shanghai Baixin'an Biotechnology 2014, Pudong (China), Public | Developer of coronary stent system | $15.8M | 40/100 | |
31st | Maxwell Biomedical 2019, Solana Beach (United States), Seed | Developer of smart devices for atrial fibrillation | - | 32/100 |
Looking for more details on Maxwell Biomedical's competitors? Click here to see the top ones
Maxwell Biomedical's Investments and acquisitions
Maxwell Biomedical has acquired Cardialen. Maxwell Biomedical has not made any investments as of now.News related to Maxwell Biomedical
•
•
MedTech Startup Develops New Device To Treat Atrial FibrillationSan Diego Business Journal•Jul 22, 2020•Maxwell Biomedical
Are you a Founder ?
FAQs about Maxwell Biomedical
Explore our recently published companies
- CrossTalk - 2023 founded, Unfunded company
- I9hunter.com.br - Brazil based, 2021 founded, Unfunded company
- Windmill Healthcare Services - Mumbai based, 2024 founded, Unfunded company
- Sandoz - Delhi based, 1960 founded, Unfunded company
- Tradex Theory - Pratapgarh based, 2021 founded, Unfunded company
- Electricals For You - Faridabad based, 2022 founded, Unfunded company